Clinical Trial Update: The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports on the efficacy and safety of K-001 for advanced pancreatic cancer in phase 2 and phase 3, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• K-001

Snippet

Sponsor: RenJi Hospital | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: UNKNOWN